NasdaqCM - Nasdaq Real Time Price USD
Aethlon Medical, Inc. (AEMD)
0.4142
+0.0042
+(1.02%)
At close: May 13 at 4:00:02 PM EDT
0.4400
+0.03
+(6.23%)
Pre-Market: 8:12:00 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 651.58k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BROENNIMAN EDWARD G Director | Stock Award(Grant) at price 0.35 per share. | Direct | 50,000 | Apr 23, 2025 |
| ROSSETTI ANGELA Director | Stock Award(Grant) at price 0.35 per share. | Direct | 50,000 | Apr 23, 2025 |
| SHAH CHETAN S Director | Stock Award(Grant) at price 0.36 per share. | Direct | 51,143 | Apr 23, 2025 |
| GIKAKIS NICOLAS Director | Stock Award(Grant) at price 0.35 per share. | Direct | 50,000 | Apr 23, 2025 |
| BROENNIMAN EDWARD G Director | Stock Award(Grant) at price 1.52 per share. | Direct | 49,999 | Apr 16, 2024 |
| ROSSETTI ANGELA Director | Stock Award(Grant) at price 1.52 per share. | Direct | 49,999 | Apr 16, 2024 |
| SHAH CHETAN S Director | Stock Award(Grant) at price 1.52 per share. | Direct | 49,999 | Apr 16, 2024 |
| GIKAKIS NICOLAS Director | Stock Award(Grant) at price 1.52 per share. | Direct | 49,999 | Apr 16, 2024 |
| GIKAKIS NICOLAS Director | -- | Direct | -- | Jul 3, 2023 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Apr 28, 2023 |
| ROSSETTI ANGELA Director | -- | Direct | -- | Apr 28, 2023 |
| SHAH CHETAN S Director | -- | Direct | -- | Apr 28, 2023 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Sep 15, 2022 |
| ROSSETTI ANGELA Director | -- | Direct | -- | Sep 15, 2022 |
| SHAH CHETAN S Director | -- | Direct | -- | Sep 15, 2022 |
| BROENNIMAN EDWARD G Director | Stock Award(Grant) at price 2.06 per share. | Direct | 50,048 | Apr 1, 2021 |
| JOHNSON SABRINA MARTUCCI Director | Stock Award(Grant) at price 2.06 per share. | Direct | 50,048 | Apr 1, 2021 |
| SHAH CHETAN S Director | Stock Award(Grant) at price 2.06 per share. | Direct | 50,048 | Apr 1, 2021 |
| SHAH CHETAN S Director | Sale at price 2.09 - 2.11 per share. | Direct | 56,580 | Dec 17, 2020 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Apr 3, 2020 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Apr 3, 2020 |
| JOHNSON SABRINA MARTUCCI Director | -- | Direct | -- | Apr 3, 2020 |
| JOHNSON SABRINA MARTUCCI Director | -- | Direct | -- | Apr 3, 2020 |
| FISHER CHARLES J. JR Director | -- | Direct | -- | Apr 3, 2020 |
| FISHER CHARLES J. JR Director | -- | Direct | -- | Apr 3, 2020 |
| SHAH CHETAN S Director | -- | Direct | -- | Apr 3, 2020 |
| SHAH CHETAN S Director | -- | Direct | -- | Apr 3, 2020 |
| CIPRIANI GUY F. Director | -- | Direct | -- | Apr 3, 2020 |
| CIPRIANI GUY F. Director | -- | Direct | -- | Apr 3, 2020 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Apr 1, 2019 |
| KENLEY RODNEY S President | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 1,839 | Oct 31, 2018 |
| FRAKES JAMES B Chief Financial Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 1,593 | Oct 31, 2018 |
| JOYCE JAMES A Chief Executive Officer | Conversion of Exercise of derivative security at price 1.04 per share. | Direct | 19,430 | Oct 31, 2018 |
| KENLEY RODNEY S President | -- | Direct | -- | Jul 31, 2018 |
| FRAKES JAMES B Chief Financial Officer | Conversion of Exercise of derivative security at price 1.23 per share. | Direct | 1,921 | Jul 31, 2018 |
| JOYCE JAMES A Chief Executive Officer | Conversion of Exercise of derivative security at price 1.23 per share. | Direct | 22,980 | Jul 31, 2018 |
| BROENNIMAN EDWARD G Director | -- | Direct | -- | Jun 14, 2018 |
| FRAKES JAMES B Chief Financial Officer | -- | Direct | -- | Jun 14, 2018 |
| JOHNSON SABRINA MARTUCCI Director | -- | Direct | -- | Jun 14, 2018 |
| FISHER CHARLES J. JR Director | -- | Direct | -- | Jun 14, 2018 |
| SHAH CHETAN S Director | -- | Direct | -- | Jun 14, 2018 |
| KENLEY RODNEY S President | -- | Direct | -- | Apr 30, 2018 |
| FRAKES JAMES B Chief Financial Officer | -- | Direct | -- | Apr 30, 2018 |
| FRAKES JAMES B Chief Financial Officer | -- | Direct | -- | Apr 30, 2018 |
| JOYCE JAMES A Chief Executive Officer | -- | Direct | -- | Apr 30, 2018 |
| JOHNSON SABRINA MARTUCCI Director | -- | Direct | -- | Feb 6, 2018 |
| KENLEY RODNEY S President | -- | Direct | -- | Jan 31, 2018 |
| FRAKES JAMES B Chief Financial Officer | -- | Direct | -- | Jan 31, 2018 |
| JOYCE JAMES A Chief Executive Officer | -- | Direct | -- | Dec 29, 2017 |
| KENLEY RODNEY S Officer and Director | Conversion of Exercise of derivative security at price 0.98 per share. | Direct | 1,733 | Oct 30, 2017 |
Related Tickers
VTAK Catheter Precision, Inc.
0.3070
+4.46%
OPGN OpGen, Inc.
4.8500
+1.04%
BBLG Bone Biologics Corporation
0.7750
+6.14%
AXDX Accelerate Diagnostics, Inc.
0.0880
-34.38%
CTSO Cytosorbents Corporation
0.8700
-0.01%
CODX Co-Diagnostics, Inc.
0.3623
+6.06%
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.5600
0.00%
NAOV NanoVibronix, Inc.
3.9900
-2.92%
TIVC Tivic Health Systems, Inc.
4.0100
-5.20%
TNON Tenon Medical, Inc.
1.2400
-5.34%